July 23, 2026

Breakthrough Prize for former MPI scientist

Breakthrough Prize for former MPI scientist

Physicist Ulrich Haeberlen contributed to the award-winning “Myon g-2” project through his research.

July 16, 2026

An international research group has been awarded the “Breakthrough Prize for Fundamental Physics” for its decades of work on the “Myon g-2” particle physics experiment. Among the 387 laureates is a former researcher at the Max Planck Institute for Medical Research, physicist Ulrich Haeberlen.

The central element of the “Myon g-2” experiment is the giant storage ring at the Fermi National Accelerator Laboratory (Fermilab) near Chicago (USA).
© Fermi National Accelerator Laboratory
  • With this year’s Breakthrough Prize for Fundamental Physics, the jury honored researchers who measured the anomalous magnetic moment of the elementary particle, the muon, with exceptional precision.
  • Ulrich Haeberlen conducted research in the 1970s and 1980s at the Max Planck Institute for Medical Research in the field of nuclear magnetic resonance spectroscopy.
  • The physicist is one of more than 300 living co-authors whose measurement campaigns contributed to the award-winning project.

Decades of research

The “Muon g-2” particle physics experiment is a collaborative project involving research groups from the Fermi National Accelerator Laboratory (Fermilab) in the U.S., the CERN research center (Switzerland/France), and the Brookhaven National Laboratory (U.S.). The main component of the experiment was a giant superconducting magnetic ring. In this magnetic ring, muons – unstable elementary particles similar to electrons – were accelerated to nearly the speed of light and their subtle “wobbles” in the magnetic field were measured.

The final results, published in 2025, confirmed earlier anomalies that could be an important indication of new physical laws beyond the Standard Model. In doing so, the researchers demonstrated years of perseverance in their search for answers to fundamental questions in physics. Their experiments were recognized for their extraordinary precision.

A leading figure in the experiments

During his time at the Max Planck Institute for Medical Research (MPIMR), Heidelberg physicist Ulrich Haeberlen played a leading role in three of the four major experiments of the award-winning “Myon g-2” project by reporting his measurement results and publications to Brookhaven National Laboratory in the United States.

In 1969, Ulrich Haeberlen joined the Department of Molecular Physics at the MPIMR as a research associate. There, he conducted independent basic research in the field of nuclear magnetic resonance spectroscopy. In 1975, he earned his habilitation with a thesis on high-resolution nuclear magnetic resonance in solids. From 1987 until his retirement in 1999, Ulrich Haeberlen headed the Molecular Crystals Research Group.

The “Oscar” of science prizes

With a prize fund of three million dollars, the Breakthrough Prize is considered one of the world’s most lucrative research awards in the natural sciences and is known as the “Oscar” of science. In addition to fundamental physics, it is awarded in the categories of life sciences (biological sciences and medicine) and mathematics to individuals who have made profound contributions to human knowledge.

The award ceremony took place in April 2026 in California in the presence of many celebrities from the film industry, elite sports, and the tech industry.

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp